Company / Current Assets
Vaxcyte, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.6B
FY2025
5-year range
$256.3M / $1.8B
FY2021-FY2025
Trend
-9.0%
vs FY2024
Sector context
#36 of 213
Health Care
What the data says
Vaxcyte, Inc.'s current assets of $1.6B is higher than 83% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 7 years, ranging from $62M in FY2019 to $1.8B in FY2024.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of +33.1%. Top quartile in the Health Care sector.
Improved from $1.1B to $1.6B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +20.0%
- 5-Year CAGR
- +33.1%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 213This company $1.6B Sector average $2.5B
▼
-35.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +33.1%, indicating consistent growth.
- In FY2025, current assets decreased 9.0% year-over-year.
- Ranks #36 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | -9.0% |
| FY2024 | $1.8B | +63.1% |
| FY2023 | $1.1B | +16.3% |
| FY2022 | $942.6M | +267.7% |
| FY2021 | $256.3M | -34.1% |
| FY2020 | $389.0M | +530.2% |
| FY2019 | $61.7M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026